ClinicalTrials.Veeva

Menu
H

Hospital Taiping | Clinical Research Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relamorelin
Pimodivir
Linagliptin
Ritonavir
Sisunatovir
PF-00489791
Aldosterone bloCkade
Apixaban
Olezarsen
PF-04634817

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 22 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from ba...

Active, not recruiting
Severe Hypertriglyceridemia
Drug: Placebo
Drug: Olezarsen

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Allergan logo
Pfizer logo
M
Boehringer Ingelheim logo
Ionis Pharmaceuticals logo
L
Population Health Research Institute (PHRI) logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems